Related Experiment Videos

[Recent progress in the research of mood disorder]

Teruhiko Higuchi

Nihon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics

|October 29, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

A Multicenter, Open-Label Study to Evaluate the Long-term Safety and Efficacy of Adjunctive Brexpiprazole 2 mg Daily in Japanese Patients with Major Depressive Disorder.

CNS drugs·2024

Adjunctive brexpiprazole 1 mg and 2 mg daily for Japanese patients with major depressive disorder following inadequate response to antidepressants: a phase 2/3, randomized, double-blind (BLESS) study.

Psychiatry and clinical neurosciences·2023

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study.

Neuropsychiatric disease and treatment·2021

Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study.

International journal of bipolar disorders·2021

Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6-week, randomized, double-blind, placebo-controlled study.

Psychiatry and clinical neurosciences·2021

Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study.

Journal of affective disorders·2020

See all related articles